| 000 | 01541nam a2200385 i 4500 | ||
|---|---|---|---|
| 999 |
_c261348 _d261348 |
||
| 001 | ocn993630909 | ||
| 003 | BD | ||
| 005 | 20180117145232.0 | ||
| 006 | m o d f | ||
| 007 | cr bn||||a|||| | ||
| 008 | 170713s2017 dcu o f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _epn _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 049 | _aBDDF | ||
| 050 | 1 | 4 |
_aKF32 _b.E55 2017 |
| 074 | _a1008-D (MF) | ||
| 086 | 0 | _aY 1.1/8:115-201 | |
| 099 | _aY 1.1/8:115-201 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce, _eauthor. |
|
| 245 | 1 | 0 |
_aFDA Reauthorization Act of 2017 : _breport (to accompany H.R. 2430). |
| 264 | 1 |
_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c[2017] |
|
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_amicroform _bh _2rdamedia |
||
| 338 |
_amicrofiche _bhe _2rdacarrier |
||
| 490 | 1 |
_aReport / 115th Congress, 1st session, House of Representatives ; _v115-201 |
|
| 500 | _a"July 11, 2017." | ||
| 500 | _aCRDP Program record. | ||
| 588 | _aDescription based on online resource, PDF version; title from caption (FDsys web site, viewed on July 13, 2017). | ||
| 650 | 0 |
_aDrug testing _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aMedical instruments and apparatus _xTesting _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aUser charges _xLaw and legislation _zUnited States. |
|
| 655 | 7 |
_aLegislative materials. _2lcgft |
|
| 810 | 1 |
_aUnited States. _bCongress. _bHouse. _tReport ; _v115-201. |
|
| 856 | 4 | 0 | _uhttp://purl.fdlp.gov/GPO/gpo82631 |
| 942 |
_2sudocs _c12 |
||